Sera Prognostics Stock (NASDAQ: SERA) stock price, news, charts, stock research, profile.
Open | $5.51 |
Close | $5.38 |
Volume / Avg. | 82.22K / 209.91K |
Day Range | 5.36 - 5.74 |
52 Wk Range | 1.52 - 12.36 |
Market Cap | $179.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 26 |
Short Interest | 0.78% |
Days to Cover | 2.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sera Prognostics (NASDAQ:SERA) through any online brokerage.
Other companies in Sera Prognostics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Opthea (NASDAQ:OPT) and Genfit (NASDAQ:GNFT).
There is no analysis for Sera Prognostics.
Sera Prognostics has a consensus price target of $7.63.
The stock price for Sera Prognostics (NASDAQ: SERA) is $5.5 last updated July 3, 2024 at 3:54 PM EDT.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.